Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients-Reference-Cited by-同舟云学术

Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients

Published:2020-07-31 Issue:9 Volume:41 Page:1167-1177
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Su Hai-xia,Yao Sheng,Zhao Wen-feng,Li Min-jun,Liu Jia,Shang Wei-juan,Xie Hang,Ke Chang-qiang,Hu Hang-chen,Gao Mei-na,Yu Kun-qian,Liu Hong,Shen Jing-shan,Tang Wei,Zhang Lei-ke,Xiao Geng-fu,Ni Li,Wang Dao-wen,Zuo Jian-ping,Jiang Hua-liang,Bai Fang,Wu Yan,Ye Yang,Xu Ye-chun

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/s41401-020-0483-6.pdf

Reference43 articles.

1. Zumla A, Chan JFW, Azhar EI, Hui DSC, Yuen KY. Coronaviruses—drug discovery and therapeutic options. Nat Rev Drug Discov. 2016;15:327–47.

2. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523–34.

3. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–207.

4. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–23.

5. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3.

Cited by 355 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11

2. Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor;Current Medicinal Chemistry;2024-11

3. Proteomic analysis reveals the antiviral effects of baicalin on pseudorabies virus;International Journal of Biological Macromolecules;2024-10

4. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10

5. A comprehensive study of SARS-CoV-2 mfigain protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system;PLOS Pathogens;2024-09-11